ZA986337B - Pyrazine derivatives their preparation and medicaments containing them - Google Patents

Pyrazine derivatives their preparation and medicaments containing them

Info

Publication number
ZA986337B
ZA986337B ZA986337A ZA986337A ZA986337B ZA 986337 B ZA986337 B ZA 986337B ZA 986337 A ZA986337 A ZA 986337A ZA 986337 A ZA986337 A ZA 986337A ZA 986337 B ZA986337 B ZA 986337B
Authority
ZA
South Africa
Prior art keywords
ch2oh
alk
choh
equal
preparation
Prior art date
Application number
ZA986337A
Other languages
English (en)
Inventor
Georges Bashiardes
Jean-Christophe Carry
Michel Evers
Bruno Filoche
Serge Mignani
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA986337B publication Critical patent/ZA986337B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA986337A 1997-07-17 1998-07-16 Pyrazine derivatives their preparation and medicaments containing them ZA986337B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9709058A FR2766187B1 (fr) 1997-07-17 1997-07-17 Derives de pyrazine, leur preparation et les medicaments les contenant

Publications (1)

Publication Number Publication Date
ZA986337B true ZA986337B (en) 1999-01-27

Family

ID=9509300

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA986337A ZA986337B (en) 1997-07-17 1998-07-16 Pyrazine derivatives their preparation and medicaments containing them

Country Status (24)

Country Link
US (1) US6399613B1 (de)
EP (1) EP1001944B1 (de)
JP (1) JP4443036B2 (de)
KR (1) KR20010021901A (de)
CN (1) CN1264371A (de)
AT (1) ATE251144T1 (de)
AU (1) AU747127B2 (de)
BR (1) BR9810880A (de)
CA (1) CA2296727C (de)
DE (1) DE69818679T2 (de)
DK (1) DK1001944T3 (de)
ES (1) ES2205536T3 (de)
FR (1) FR2766187B1 (de)
HU (1) HUP0004602A3 (de)
IL (1) IL134040A0 (de)
MX (1) MXPA00000280A (de)
NO (1) NO20000198L (de)
NZ (1) NZ501906A (de)
PL (1) PL338148A1 (de)
PT (1) PT1001944E (de)
RU (1) RU2194703C2 (de)
SK (1) SK482000A3 (de)
WO (1) WO1999003844A1 (de)
ZA (1) ZA986337B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9905771D0 (en) * 1999-03-12 1999-05-05 Isis Innovation Compounds
US7598278B2 (en) 2002-04-11 2009-10-06 L'oreal Administration of pyridinedicarboxylic acid compounds for stimulating or inducing the growth of human keratinous fibers and/or arresting their loss
JP2008521847A (ja) * 2004-12-03 2008-06-26 エフ.ホフマン−ラ ロシュ アーゲー H3拮抗剤としての3−置換ピリジン誘導体
JP2008543953A (ja) * 2006-04-20 2008-12-04 テバ ファーマシューティカル インダストリーズ リミティド エスゾピクロン結晶形態a、実質的に純粋なエスゾピクロン及び光学的に豊富なエスゾピクロンを調製するための方法
WO2008002629A1 (en) * 2006-06-26 2008-01-03 Teva Pharmaceutical Industries Ltd. Process for the preparation of zopiclone
WO2008094690A2 (en) * 2007-01-31 2008-08-07 Teva Pharmaceutical Industries Ltd. Methods for preparing eszopiclone
CN101891679B (zh) * 2009-05-19 2014-04-16 上海华明高技术(集团)有限公司 吡啶二甲酸与二氨基吡啶质子转移化合物的制备方法
FR3030248B1 (fr) 2014-12-22 2018-03-23 L'oreal Association derive d'acide pyridine-dicarboxylique/agent anti-oxydant particulier
EP4687881A2 (de) * 2023-03-31 2026-02-11 Flexsys IP Holdings, LLC Heteroaryl-antiabbaumittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220650A (en) * 1978-10-18 1980-09-02 Pfizer Inc. Organic diamine therapeutic compositions and methods
DE3703959A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
JPH01117863A (ja) * 1987-10-30 1989-05-10 Toyobo Co Ltd 新規なアミド化合物
DE4020570A1 (de) * 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung

Also Published As

Publication number Publication date
MXPA00000280A (es) 2002-04-17
IL134040A0 (en) 2001-04-30
FR2766187A1 (fr) 1999-01-22
DK1001944T3 (da) 2004-02-09
CA2296727A1 (fr) 1999-01-28
ES2205536T3 (es) 2004-05-01
WO1999003844A1 (fr) 1999-01-28
HUP0004602A3 (en) 2001-12-28
NO20000198D0 (no) 2000-01-14
NO20000198L (no) 2000-01-14
EP1001944B1 (de) 2003-10-01
ATE251144T1 (de) 2003-10-15
AU747127B2 (en) 2002-05-09
HUP0004602A2 (hu) 2001-11-28
DE69818679D1 (de) 2003-11-06
US6399613B1 (en) 2002-06-04
RU2194703C2 (ru) 2002-12-20
SK482000A3 (en) 2000-06-12
NZ501906A (en) 2002-04-26
FR2766187B1 (fr) 2000-06-02
CA2296727C (fr) 2009-06-09
EP1001944A1 (de) 2000-05-24
KR20010021901A (ko) 2001-03-15
JP2001510188A (ja) 2001-07-31
BR9810880A (pt) 2002-05-21
JP4443036B2 (ja) 2010-03-31
AU8810298A (en) 1999-02-10
PT1001944E (pt) 2004-02-27
CN1264371A (zh) 2000-08-23
DE69818679T2 (de) 2004-07-29
PL338148A1 (en) 2000-09-25

Similar Documents

Publication Publication Date Title
SI0641767T1 (en) Cytotoxic stilbene derivatives and pharmaceutical composition containing them
FR2672598B1 (de)
IE830785L (en) Pharmaceutical compositions containing oxicam derivatives
MY108076A (en) Cationic compound and cleaning composition.
ZA986337B (en) Pyrazine derivatives their preparation and medicaments containing them
IL70905A0 (en) Carbacycline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ES2136691T3 (es) Poliuretanos ignifugos.
IL123884A0 (en) Active oxygen scavengers containing pterin derivatives
IE45090L (en) N-phosphonomethylene - aminoalkane phosphonic acids.
DE69029781D1 (de) Anthracyclinglycosid-Derivate und Verfahren zu ihrer Herstellung
SE9701912D0 (sv) Pharmaceutical composition and use thereof
TW328083B (en) New derivatives of β-methoxy acrylic acid, their preparation process and their use as pesticides
AU539348B2 (en) 5,6,8,9-tetrahydro-7h-dibenz(d,f)azonine derivatives
IL86795A (en) 8-substituted ergoline-6-oxide derivatives,their preparation and pharmaceutical compositions containing them
DE3864336D1 (en) Aromatische thioaether.
FR2551068B1 (fr) Nouveaux derives de nitrosourees, leurs procedes de preparation et compositions therapeutiques les contenant
ATE44281T1 (de) Benzoselenino(4,3,2-cd>indazolverbindungen, diese enthaltende zubereitungen und verfahren zu ihrer herstellung.
EP0361510A3 (en) Antitumor substance, process for preparing the same, and anticancer agent containing the same